Drugs / EC90
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00485563 | Jun 2007 → Aug 2008 | renal cell carcinoma | Endocyte | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC90 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00485563 ↗ |
| Known as | KLH-FITC | “EC90 (KLH-FITC)” NCT00485563 ↗ |
| Modality | Vaccine | “vaccination with EC90” NCT00485563 ↗ |
| Route | Subcutaneous | “subcutaneous vaccinations with EC90” NCT00485563 ↗ |